Pulse Biosciences Inc
NASDAQ:PLSE

  • LAST PRICE
    12.0300
  • TODAY'S CHANGE (%)
    -0.1700 (-1.3934%)
  • Bid / Lots
    11.4100/ 1
  • Ask / Lots
    13.2400/ 1
  • Open / Previous Close
    11.9700 / 12.2000
  • Day Range
    11.6040
    12.4000
  • 52 Week Range
    3.7800
    14.9600
  • Volume
    77,073

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Jun 4, 2024

  • May 20, 2024

      Show headlines and story abstract

    • 5:39PM ET on Monday May 20, 2024 by MT Newswires
      Companies Mentioned: PLSE
      05:39 PM EDT, 05/20/2024 (MT Newswires) -- Pulse Biosciences (PLSE) said late Monday that its board determined a new record date May 31 for its rights offering, moving it from May 16. The company plans to distribute subscription rights for purchasin...

    • 4:05PM ET on Monday May 20, 2024 by Business Wire
      Companies Mentioned: PLSE

      Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX(R) Nanosecond Pulsed Field Ablation(TM) (nsPFA(TM)) technology, today announced that the Company's Board of Directors has determined a new record date for the Company's previously announced rights offering (the "Rights Offering"), which will be available to all holders of record of the Company's common stock, par value $0.001 per share (the "Common Stock"), now as of the close of the market on Friday, May 31, 2024 (the "Record Date"). This new record date was changed from the original record date of May 16, 2024.

    • 4:05PM ET on Monday May 20, 2024 by Dow Jones
      Companies Mentioned: PLSE
      HAYWARD, Calif.--(BUSINESS WIRE)--May 20, 2024--
      Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX(R) Nanosecond Pulsed Field Ablation(TM) (nsPFA(TM)) technology, today announced that the Company's Board of Directors has determined a new record date for the Company's previously announced rights offering (the "Rights Offering"), which will be available to all holders of record of the Company's common stock, par value $0.001 per share (the "Common Stock"), now as of the close of the market on Friday, May 31, 2024 (the "Record Date"). This new record date was changed from the original record date of May 16, 2024.

Peers Headlines